Petrelintide Tolerability Could Improve on GLP-1 Challenges

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows.
Medscape Medical News

source https://www.medscape.com/viewarticle/petrelintide-tolerability-could-improve-glp-1-challenges-2026a1000iy7?src=rss